These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 62946)
1. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946 [TBL] [Abstract][Full Text] [Related]
2. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047 [TBL] [Abstract][Full Text] [Related]
3. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175 [TBL] [Abstract][Full Text] [Related]
4. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study. Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490 [TBL] [Abstract][Full Text] [Related]
5. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S; Sasaki M; Kobayashi T; Matsuda T Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
6. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028 [TBL] [Abstract][Full Text] [Related]
7. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029 [TBL] [Abstract][Full Text] [Related]
8. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
9. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report). Somner AR Lancet; 1980 May; 1(8179):1182-3. PubMed ID: 6103997 [No Abstract] [Full Text] [Related]
10. Present status of chemotherapy for tuberculosis. Grosset JH Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251 [TBL] [Abstract][Full Text] [Related]
11. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
12. Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis. Tubercle; 1977 Mar; 58(1):1-8. PubMed ID: 325837 [TBL] [Abstract][Full Text] [Related]
13. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study. Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933 [TBL] [Abstract][Full Text] [Related]
14. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related]
15. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199 [TBL] [Abstract][Full Text] [Related]
16. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
17. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol]. Baba H; Schinkai A; Izuchi R; Azuma Y Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792 [No Abstract] [Full Text] [Related]
18. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE; Zierski M; Graczyk J; Bek E; Farer LS Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [TBL] [Abstract][Full Text] [Related]
19. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200 [TBL] [Abstract][Full Text] [Related]
20. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]